Evidence map›Paper›PMID 31475462›Full record

SynthesisCancer medicine2019

Revisit of an unanswered question by pooled analysis of eight cohort studies in Japan: Does cigarette smoking and alcohol drinking have interaction for the risk of esophageal cancer?

Isao Oze, Hadrien Charvat, Keitaro Matsuo, Hidemi Ito, Akiko Tamakoshi, Chisato Nagata, Keiko Wada, Yumi Sugawara, Norie Sawada, Taiki Yamaji and 6 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Cancer medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Oncologists' communication about tobacco and alcohol use during treatment for esophagogastric cancer: a qualitative observational study of simulated consultations.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1.Esophagus : official journal of the Japan Esophageal Society · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Isao OzeDivision of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0002-0762-1147
Hadrien CharvatEpidemiology and Prevention Group, Research Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.ORCID 0000-0003-3624-1394
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0003-1761-6314
Hidemi ItoDivision of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID 0000-0002-8023-4581
Akiko TamakoshiDepartment of Public Health, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Chisato NagataDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
Keiko WadaDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.ORCID 0000-0002-5467-8592
Yumi SugawaraDivision of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID 0000-0002-0197-6772
Norie SawadaEpidemiology and Prevention Group, Research Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.ORCID 0000-0002-9936-1476
Taiki YamajiEpidemiology and Prevention Group, Research Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Mariko NaitoDepartment of Oral Epidemiology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Keitaro TanakaDepartment of Preventive Medicine, Saga Medical School, Faculty of Medicine, Saga University, Saga, Japan.
Taichi ShimazuEpidemiology and Prevention Group, Research Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Tetsuya MizoueDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Shoichiro TsuganeEpidemiology and Prevention Group, Research Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Manami InoueEpidemiology and Prevention Group, Research Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

Funding

Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer 3jigan-ippan-003Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer H16-3jigan-010Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer H18-3jigan-ippan-001National Cancer Center Research and Development Fund 24-A-3National Cancer Center Research and Development Fund 27-A-4National Cancer Center Research and Development Fund 30-A-15
6 · The paper itself

Abstract

Cigarette smoking and alcohol drinking are two major risk factors for esophageal cancer. Not all, but several of case-control studies have indicated interaction between the two factors; however, no prospective study has validated this phenomenon to date. Therefore, the interaction between smoking and alcohol drinking is still open-ended question. To answer this, we conducted a pooled analysis using large-scale population-based cohort studies in Japan. Male subjects from eight cohort studies were included. Cigarette smoking and alcohol drinking were both categorized categorically (never/ever), and in the three consumption levels of pack years and ethanol consumption/day. Effects of smoking and drinking in each study were estimated by Cox regression models. The study-specific results were combined through meta-analysis to obtain summary effects of hazard ratios (HRs) and measures of interactions at both additive and multiplicative scales. Population attributable fractions (PAFs) from smoking and drinking were obtained using distributions of exposures and fully adjusted HRs. In 162 826 male subjects, 954 esophageal cancer incidences were identified. HRs of ever smoking, ever drinking, and their combination were 2.92 (1.59-5.36), 2.73 (1.78-4.18), and 8.86 (4.82-16.30), respectively. Interaction between cigarette smoking and alcohol drinking was significantly positive on the additive scale, but not significant on the multiplicative scale. The joint effect of smoking and drinking in three levels of evaluation showed a similar significant super-additive interaction. PAFs from smoking, drinking, and their combination were 55.4%, 61.2%, and 81.4%, respectively. Cigarette smoking and alcohol drinking had a significant positive additive interaction for esophageal cancer risk.

Indexed as

Alcohol DrinkingCigarette SmokingDisease SusceptibilityEsophageal NeoplasmsFemaleHumansJapanMaleModels, TheoreticalPublic Health SurveillanceRisk AssessmentRisk Factorsalcohol drinkingcigarette smokingesophageal cancerinteractionpooled analysis

Identifiers

PMID31475462
PMCPMC6797581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.